Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications
Open Access
- 10 June 2026
- journal article
- review article
- Published by Wiley in Contact Dermatitis
- Vol. 95 (4) , 349-357
Abstract
Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis. However, its role in paediatric DHRs remains unclear. Available data indicate that PT is safe and particularly useful when drug provocation testing is contraindicated, such as in patients with severe cutaneous adverse reactions. However, diagnostic yield varies considerably among drug classes and clinical phenotypes. Sensitivity is generally low for beta‐lactam and most non–beta‐lactam antibiotics, which limits their standalone value in common exanthematous reactions. Higher positivity rates have been reported for antiepileptic drugs, and PT may help identify the culprit drug and assess its cross‐reactivity. However, evidence supporting the use of nonsteroidal anti‐inflammatory drugs and paracetamol remains scarce. Methodological heterogeneity and limited paediatric‐specific data further constrain this interpretation. Overall, PT should be considered as a complementary diagnostic tool integrated with clinical history and other tests, highlighting the need for standardized protocols and prospective paediatric studies.Keywords
This publication has 38 references indexed in Scilit:
- Progressively Simplified Testing in the Evaluation of Nonimmediate Reactions to PenicillinsThe Journal of Allergy and Clinical Immunology: In Practice, 2025
- Delayed Skin Testing for Systemic Medications: Helpful or Not?The Journal of Allergy and Clinical Immunology: In Practice, 2024
- Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysisAnnals of Allergy, Asthma & Immunology, 2023
- Drug allergy: A 2022 practice parameter updateJournal of Allergy and Clinical Immunology, 2022
- Patch testing: Uses, systems, risks/benefits, and its role in managing the patient with contact dermatitisClinics in Dermatology, 2021
- Pediatric allergic contact dermatitis. Part 2: Patch testing series, procedure, and unique scenariosJournal of the American Academy of Dermatology, 2021
- Two approaches for diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity in childrenAnnals of Allergy, Asthma & Immunology, 2019
- InternationalConsensus on drug allergyAllergy, 2014
- The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting DrugImmunology and Allergy Clinics of North America, 2009
- Drug patch testing in systemic cutaneous drug allergyToxicology, 2005